Brief: Annexin Pharmaceuticals Q4 Net Loss Widens To SEK 9.6 Mln
Jan 31 (Reuters) - ANNEXIN PHARMACEUTICALS AB (PUBL)
ANNX.ST :
* Q4 NET LOSS SEK 9.6 MILLION VERSUS LOSS SEK 3.5 MILLION
Source text for Eikon: ID:nWkr7JtWv
Further company coverage: ANNX.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed